Fundraising Fox

MicroVascular Tissues

San Diego, US · Founded 2014 · Delaware corporation

MicroVascular Tissues develops mVASC, a disk of human cadaver-derived extracellular matrix (ECM) harvested from skin hypodermis and containing microvascular tissues. The product is used for the repair, reconstruction, replacement, or supplementation of damaged ECM in skin defects extending through the dermis into the hypodermis.

BiotechHealthtechMedical Devices

Founders & leadership

GG
GLEN G. GONGPRESIDENT & CHIEF EXECUTIVE OFFICER
BA
Brent AtkinsonVice President & Chief Operating Officer
GG
Glen G. GongPresident & Chief Executive Officer

Board

KO
KEVIN OHASHIBoard director
DL
DALE L. PETERSONBoard director
DR
Dale R. PetersonBoard director
KL
Kevin L. OshasiBoard director

Reported raises · per SEC filings

Form D private placements

$11.9M disclosed across 5 rounds · 2014–2023

▶$4.1MraisedMar 2023 · 15 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Glen GongExecutive Officer, Director
  • Dale PetersonDirector
  • Kevin OhashiDirector
Offering amount
$6.1M
Amount sold
$4.1M
Minimum investment
$25K
Proceeds to insiders
$400K
First sale
Feb 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.5MraisedSep 2018 · 21 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Dale L PetersonDirector
  • Kevin OhashiDirector
  • Glen G GongExecutive Officer, Director
Offering amount
$8M
Amount sold
$3.5M
Minimum investment
$25K
Proceeds to insiders
$400K
First sale
Aug 2018
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.3MraisedDec 2016 · 9 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • KEVIN OHASHIDirector
  • GLEN G. GONGExecutive Officer, Director
  • DALE L. PETERSONDirector
Offering amount
$3.5M
Amount sold
$2.3M
Proceeds to insiders
$400K
First sale
Dec 2016
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedAug 2014 · 16 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Glen G. GongExecutive Officer, Director
  • Dale R. PetersonExecutive Officer, Director
  • Kevin L. OshasiExecutive Officer, Director
Offering amount
$2M
Amount sold
$2M
Minimum investment
$25K
Proceeds to insiders
$350K
First sale
Aug 2014
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5KraisedMay 2014 · 7 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Dale R. PetersonDirector
  • Kevin L. OshasiDirector
  • Brent AtkinsonExecutive Officer
  • Glen G. GongExecutive Officer, Director
Offering amount
$5K
Amount sold
$5K
First sale
Mar 2014
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
NeuroVasc5 shared keywordsNeuroVasc Technologies develops catheter-based medical devices designed to treat stroke and other neurological conditions. The company serves patients and healthcare providers requiring neurovascular interventions.

Companies competing with MicroVascular Tissues for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does MicroVascular Tissues do?
MicroVascular Tissues develops mVASC, a disk of human cadaver-derived extracellular matrix (ECM) harvested from skin hypodermis and containing microvascular tissues. The product is used for the repair, reconstruction, replacement, or supplementation of damaged ECM in skin defects extending through the dermis into the hypodermis.
How much funding has MicroVascular Tissues raised?
MicroVascular Tissues has disclosed $11.9M raised across 5 rounds.
Where is MicroVascular Tissues headquartered?
MicroVascular Tissues is headquartered in San Diego, US.